The crystal structure of the title compound, C18H13NO4, the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol-ecules parallel to the [111] crystallographic direction and by stacking inter-actions between rings [centroid-centroid distance between quinone rings = 3.684 (3) Å and between amino-benzoate rings = 4.157 (3) Å] along the ribbons.
CITATION STYLE
Bambagiotti-Alberti, M., Bartolucci, G., Bruni, B., Coran, S., & Di Vaira, M. (2008). 3-Methyl-1,4-dioxo-1,4-dihydro-naphthalen-2-yl 4-amino-benzoate. Acta Crystallographica Section E: Structure Reports Online, 64(4). https://doi.org/10.1107/S1600536808005308
Mendeley helps you to discover research relevant for your work.